DEC orders changes at Great Lakes Cheese after Ischua Creek fish kill
Breaking News
DEC orders changes at Great Lakes Cheese after Ischua Creek fish kill
By BOB CLARK bclark@oleantimesherald.com 
August 29, 2025
FRANKLINVILLE — State environmental officers said immediate changes are needed after a fish kill in Ischua Creek was triggered by pollution from the G...
Home Online Features FDA Accepts LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease
FDA Accepts LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease
Hand-out
Press Releases
Eisai Inc.  
January 14, 2025

FDA Accepts LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

LEQEMBI is the only FDA-approved anti-amyloid therapy that potentially could offer the convenience of a subcutaneous injection with at-home administration option

avatar profile Olean Times Herald

Olean Times Herald

email Olean Times Herald

Local & Social